208 related articles for article (PubMed ID: 21877179)
1. First case of anti-ganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection.
Maurissen I; Jeurissen A; Strauven T; Sprengers D; De Schepper B
Infection; 2012 Jun; 40(3):323-6. PubMed ID: 21877179
[TBL] [Abstract][Full Text] [Related]
2. Dysgeusia in a Patient with Guillain-Barré Syndrome Associated with Acute Hepatitis E: A Case Report and Literature Review.
Higuchi MA; Fukae J; Tsugawa J; Ouma S; Takahashi K; Mishiro S; Tsuboi Y
Intern Med; 2015; 54(12):1543-6. PubMed ID: 26073247
[TBL] [Abstract][Full Text] [Related]
3. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barre syndrome caused by hepatitis E infection: case report and literature review.
Zheng X; Yu L; Xu Q; Gu S; Tang L
BMC Infect Dis; 2018 Jan; 18(1):50. PubMed ID: 29357816
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis E virus-associated Guillain-Barre syndrome: Revision of the literature.
Liu H; Ma Y
Brain Behav; 2020 Jan; 10(1):e01496. PubMed ID: 31828968
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome associated with preceding hepatitis E virus infection.
van den Berg B; van der Eijk AA; Pas SD; Hunter JG; Madden RG; Tio-Gillen AP; Dalton HR; Jacobs BC
Neurology; 2014 Feb; 82(6):491-7. PubMed ID: 24415572
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barré Syndrome.
Stevens O; Claeys KG; Poesen K; Saegeman V; Van Damme P
JAMA Neurol; 2017 Jan; 74(1):26-33. PubMed ID: 27820624
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
[TBL] [Abstract][Full Text] [Related]
10. Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.
Cats EA; van der Pol WL; Tio-Gillen AP; Diekstra FP; van den Berg LH; Jacobs BC
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):502-4. PubMed ID: 25157033
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome with exaggerated pleocytosis and anti-GM1 ganglioside antibodies.
Doctor GT; Alexander SK; Radunovic A
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29306858
[TBL] [Abstract][Full Text] [Related]
12. [Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient].
Comont T; Bonnet D; Sigur N; Gerdelat A; Legrand-Abravanel F; Kamar N; Alric L
Rev Med Interne; 2014 May; 35(5):333-6. PubMed ID: 24080239
[TBL] [Abstract][Full Text] [Related]
13. Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry.
Susuki K; Odaka M; Mori M; Hirata K; Yuki N
Neurology; 2004 Mar; 62(6):949-56. PubMed ID: 15037698
[TBL] [Abstract][Full Text] [Related]
14. [Guillain-Barré syndrome in a child with normal tendon reflexes].
Tellier S; Gerdelat-Mas A; Karsenty C; Cancès C; Tison C; Chaix Y; Cheuret E
Arch Pediatr; 2012 Jan; 19(1):51-4. PubMed ID: 22154102
[TBL] [Abstract][Full Text] [Related]
15. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
16. A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy.
Ji SB; Lee SS; Jung HC; Kim HJ; Kim HJ; Kim TH; Jung WT; Lee OJ; Song DH
Clin Mol Hepatol; 2016 Sep; 22(3):396-399. PubMed ID: 27572076
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
[TBL] [Abstract][Full Text] [Related]
19. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
[TBL] [Abstract][Full Text] [Related]
20. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
